Logo image of AIM.CA

AIMIA INC (AIM.CA) Stock Fundamental Analysis

Canada - TSX:AIM - CA00900Q1037 - Common Stock

3.21 CAD
+0.01 (+0.31%)
Last: 9/24/2025, 7:00:00 PM
Fundamental Rating

4

AIM gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 30 industry peers in the Chemicals industry. The financial health of AIM is average, but there are quite some concerns on its profitability. AIM has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year AIM has reported negative net income.
AIM had a positive operating cash flow in the past year.
In the past 5 years AIM reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: AIM reported negative operating cash flow in multiple years.
AIM.CA Yearly Net Income VS EBIT VS OCF VS FCFAIM.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

The Return On Assets of AIM (-1.00%) is better than 73.33% of its industry peers.
AIM has a Return On Equity of -2.60%. This is in the better half of the industry: AIM outperforms 70.00% of its industry peers.
The Return On Invested Capital of AIM (3.08%) is better than 70.00% of its industry peers.
Industry RankSector Rank
ROA -1%
ROE -2.6%
ROIC 3.08%
ROA(3y)8.15%
ROA(5y)2.79%
ROE(3y)1.84%
ROE(5y)-1.11%
ROIC(3y)N/A
ROIC(5y)N/A
AIM.CA Yearly ROA, ROE, ROICAIM.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200

1.3 Margins

The Operating Margin of AIM (6.35%) is better than 70.00% of its industry peers.
AIM has a better Gross Margin (26.30%) than 70.00% of its industry peers.
Industry RankSector Rank
OM 6.35%
PM (TTM) N/A
GM 26.3%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AIM.CA Yearly Profit, Operating, Gross MarginsAIM.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5K 10K

5

2. Health

2.1 Basic Checks

AIM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
AIM has more shares outstanding than it did 1 year ago.
AIM has more shares outstanding than it did 5 years ago.
AIM has a worse debt/assets ratio than last year.
AIM.CA Yearly Shares OutstandingAIM.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
AIM.CA Yearly Total Debt VS Total AssetsAIM.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

Based on the Altman-Z score of -1.89, we must say that AIM is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -1.89, AIM is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
The Debt to FCF ratio of AIM is 11.35, which is on the high side as it means it would take AIM, 11.35 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of AIM (11.35) is better than 76.67% of its industry peers.
AIM has a Debt/Equity ratio of 0.85. This is a neutral value indicating AIM is somewhat dependend on debt financing.
The Debt to Equity ratio of AIM (0.85) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 11.35
Altman-Z -1.89
ROIC/WACC0.35
WACC8.86%
AIM.CA Yearly LT Debt VS Equity VS FCFAIM.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

2.3 Liquidity

AIM has a Current Ratio of 2.79. This indicates that AIM is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.79, AIM belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
A Quick Ratio of 2.04 indicates that AIM has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.04, AIM belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.79
Quick Ratio 2.04
AIM.CA Yearly Current Assets VS Current LiabilitesAIM.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

5

3. Growth

3.1 Past

AIM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 82.67%, which is quite impressive.
The Revenue has grown by 12.18% in the past year. This is quite good.
AIM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 128.16% yearly.
EPS 1Y (TTM)82.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
Revenue 1Y (TTM)12.18%
Revenue growth 3Y400.27%
Revenue growth 5Y128.16%
Sales Q2Q%5.15%

3.2 Future

AIM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 39.23% yearly.
The Revenue is expected to grow by 5.05% on average over the next years.
EPS Next Y242.44%
EPS Next 2Y59.49%
EPS Next 3Y39.23%
EPS Next 5YN/A
Revenue Next Year3.13%
Revenue Next 2Y4.55%
Revenue Next 3Y5.05%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AIM.CA Yearly Revenue VS EstimatesAIM.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 500M 1B 1.5B 2B
AIM.CA Yearly EPS VS EstimatesAIM.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 -2

6

4. Valuation

4.1 Price/Earnings Ratio

AIM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
AIM is valuated correctly with a Price/Forward Earnings ratio of 15.13.
Based on the Price/Forward Earnings ratio, AIM is valued a bit cheaper than 80.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.80, AIM is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 15.13
AIM.CA Price Earnings VS Forward Price EarningsAIM.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

83.33% of the companies in the same industry are more expensive than AIM, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, AIM is valued cheaply inside the industry as 93.33% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 10.85
EV/EBITDA 7.52
AIM.CA Per share dataAIM.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

AIM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AIM's earnings are expected to grow with 39.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y59.49%
EPS Next 3Y39.23%

0

5. Dividend

5.1 Amount

AIM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AIMIA INC

TSX:AIM (9/24/2025, 7:00:00 PM)

3.21

+0.01 (+0.31%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-06 2025-11-06
Inst Owners3.85%
Inst Owner ChangeN/A
Ins Owners1.38%
Ins Owner ChangeN/A
Market Cap291.98M
Analysts83.33
Price Target3.95 (23.05%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.15
Dividend Growth(5Y)-24.64%
DP-103.41%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.72%
Min Revenue beat(2)-5.23%
Max Revenue beat(2)-2.2%
Revenue beat(4)1
Avg Revenue beat(4)-2.11%
Min Revenue beat(4)-5.23%
Max Revenue beat(4)2.5%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.12%
PT rev (3m)-3.12%
EPS NQ rev (1m)0%
EPS NQ rev (3m)500%
EPS NY rev (1m)0%
EPS NY rev (3m)1933.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.83%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.87%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 15.13
P/S 0.57
P/FCF 10.85
P/OCF 6.77
P/B 0.86
P/tB N/A
EV/EBITDA 7.52
EPS(TTM)-0.39
EYN/A
EPS(NY)0.21
Fwd EY6.61%
FCF(TTM)0.3
FCFY9.21%
OCF(TTM)0.47
OCFY14.76%
SpS5.66
BVpS3.72
TBVpS-0.46
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1%
ROE -2.6%
ROCE 4.27%
ROIC 3.08%
ROICexc 3.39%
ROICexgc 7.49%
OM 6.35%
PM (TTM) N/A
GM 26.3%
FCFM 5.23%
ROA(3y)8.15%
ROA(5y)2.79%
ROE(3y)1.84%
ROE(5y)-1.11%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 11.35
Debt/EBITDA 4.09
Cap/Depr 43.43%
Cap/Sales 3.15%
Interest Coverage 1.63
Cash Conversion 61.57%
Profit Quality N/A
Current Ratio 2.79
Quick Ratio 2.04
Altman-Z -1.89
F-Score7
WACC8.86%
ROIC/WACC0.35
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)82.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
EPS Next Y242.44%
EPS Next 2Y59.49%
EPS Next 3Y39.23%
EPS Next 5YN/A
Revenue 1Y (TTM)12.18%
Revenue growth 3Y400.27%
Revenue growth 5Y128.16%
Sales Q2Q%5.15%
Revenue Next Year3.13%
Revenue Next 2Y4.55%
Revenue Next 3Y5.05%
Revenue Next 5YN/A
EBIT growth 1Y251.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year12400%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y178.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y233.03%
OCF growth 3Y-53.88%
OCF growth 5YN/A